Australis Capital Inc. announces that the Company has adopted amendments to the Company's stock option plan and restricted share unit plan. Under the amended plans, the Company may grant stock options and restricted share units that in aggregate do not exceed a maximum of 15% of the issued and outstanding common shares of the Company.
Australis Capital Inc. announces that the Company has appointed Harry DeMott to its Board of Directors. Mr. DeMott has over 30 years of experience in the U.S. investment community and is a long-time operator and investor in the cannabis, media, sports and entertainment industries.
Australis Capital Inc. today announced that the Company is unable to present at the Spring Investor Summit in New York City on April 2, 2019. The Company is attending the event and will be scheduling one-on-one investor meetings April 1-2.
Australis Capital Inc. today announced that Michael Carlotti, the Company's Chief Financial Officer and Cleve Tzung, SVP, Mergers and Acquisitions, will be attending and meeting with investors at the ROTH Conference 2019, to be held March 17-19, 2019, at the Ritz-Carlton, Laguna Niguel, CA.
LAS VEGAS, Feb. 26, 2019 /CNW/ - Australis Capital Inc. (CSE: AUSA)(OTCQB: AUSAF) ("Australis" or the "Company") is pleased to announce the Company has acquired 100% of Mr. Natural Productions, Inc., ("Mr. Natural") a multiple award-winning medical and recreational cannabis brand based in California.
LAS VEGAS, Feb. 6, 2019 /CNW/ - Australis Capital Inc. (CSE: AUSA OTC: AUSAF) ("Australis" or the "Company") is pleased to announce that the Company's common shares have commenced trading on the OTCQB® Venture Market under the ticker symbol "AUSAF". The Company will continue to trade on the Canadian Securities Exchange (the "CSE") under the symbol "AUSA".
LAS VEGAS, Jan. 14, 2019 /CNW/ - Australis Capital Inc. (CSE: AUSA) ("Australis" or the "Company") is pleased to announce the Company has invested $3,000,000 USD in Folium Biosciences ("Folium"), the largest vertically integrated producer, manufacturer, and distributor of hemp-derived phytocannabinoids in the United States. Folium also owns and operates the largest phytocannabinoid extraction and purification facility in the United States, with plans for a new pharmaceutical division and the completion of their Canadian facility in 2019.
LAS VEGAS, NV, Dec. 6, 2018 /CNW/ - Australis Capital Inc. (CSE: AUSA) ("Australis" or the "Company") is pleased to announce the implementation of a rolling restricted share unit plan (the "RSU Plan") and grant of an aggregate of 2,172,500 restricted share units pursuant to the RSU Plan (each, an "RSU").